Biological E will begin large-scale manufacturing of the HPV9 vaccine once the Technology transfer is completed.

Biological E partners with China’s Recbio to produce REC603 a 9-valent HPV vaccine in India The collaboration aims to expand ...

The screening test checks for the presence of the human papillomavirus or HPV. Some types of HPV can cause changes in the ...

Low screening coverage, late diagnoses, high HIV prevalence, and limited access to treatment and vaccines are driving cervical cancer cases and deaths in South Africa. The country has a cervical ...

Jiangsu Recbio Technology and Biological E. Limited are partnering for HPV9 vaccine. Recbio will transfer technology to ...

According to the agreement, BE will receive the exclusive right to commercialise the vaccine in India and participate in ...

The US Secretary of Health and Human Services insists he will soon announce the "cause" of autism, but setting a fixed ...

The implementation of these three key pillars — vaccination, screening, and treatment — are critical in eliminating cervical ...